previous compound ID: 572 next compound
InChIKey: FFGPTBGBLSHEPO-UHFFFAOYSA-N
SMILES: C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "R Robert" "D Rotin" "DY Thomas" "SD Macknight" "J Goepp" "J Liao" "B Kus" "E Matthes" "JW Hanrahan"

chemical graph of compound 572





CID is 2554
synonyms found at PubChem are:
carbamazepine, 298-46-4, Tegretol, 5H-Dibenzo[b,f]azepine-5-carboxamide, Carbamazepen, Carbazepine, Finlepsin, Biston, Equetro, Carbamezepine, Tegretal, Epitol, Carbatrol, Neurotol, Timonil, 5H-Dibenz[b,f]azepine-5-carboxamide, Karbamazepin, Stazepine, Telesmin, Lexin, Tegretol-Xr, Carbamazepina, Carbamazepinum, Carbamazepin, Amizepin, Bipotrol, Teril, 5-Carbamyl-5H-dibenzo(b,f)azepine, 5-Carbamoyl-5H-dibenzo(b,f)azepine, Geigy 32883, Calepsin, Carnexiv, Stazepin, 5-Carbamoyl-5H-dibenz(b,f)azepine, 5H-Dibenz(b,f)azepine-5-carboxamide, benzo[b][1]benzazepine-11-carboxamide, 5-Carbamoyl-5H-dibenz[b,f]azepine, G 32883, G-32883, Carbamazepan, Carbelan, Sirtal, Tegretol Cr, Carbamazepinum [INN-Latin], Carbamazepina [INN-Spanish], NSC 169864, CHEBI:3387, UNII-33CM23913M, HSDB 3019, FFGPTBGBLSHEPO-UHFFFAOYSA-N, EINECS 206-062-7, CHEMBL108, BRN 1246090, 5-Carbamyldibenzo(b,f)azepine, MLS000069652, 5-Carbamoyldibenzo(b,f)azepine, Carbamazepine Hydrochloride, dibenzo[b,f]azepine-5-carboxamide, NSC169864, 33CM23913M, NCGC00015234-11, CAS-298-46-4, SMR000058201, carbamazepine hydrate, DSSTox_CID_2731, DSSTox_RID_76704, DSSTox_GSID_22731, Q-200792, Carbazepin, Amizepine, 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide, SMR001227191, Carbamazepine Anhydrous, Carbamazepine Phosphate, SR-01000000229, Carbatrol extended-release, Atretol, Trimonil, Neurotop retard, Novo-Carbamaz, Nu-Carbamazepine, Apo-Carbamazepine, Tegretol Chewtabs, Taro-Carbamazepine, Tegretol (TN), Prestwick_104, carbamazepine sulfate, Equetro (TN), Carbamazepine [USAN:INN:BAN:JAN], carbamazepine tartrate, Carbamazepine, powder, Taro-Carbamazepine Cr, Opera_ID_72, Spectrum_000096, Carbamazepine [USAN:USP:INN:BAN:JAN], carbamazepine (Tegretol), AC1L1DXT, AC1Q4ZSU, AC1Q4ZSV, Prestwick0_000052, Prestwick1_000052, Prestwick2_000052, Prestwick3_000052, Spectrum2_000125, Spectrum3_000325, Spectrum4_000262, Spectrum5_000936, Carbamazepine (Carbatrol), Lopac-C-4024, ChemDiv1_018966, CBChromo1_000350, D04MSM, Epitope ID:174842, Iminostilbene-N-carboxamide, Lopac0_000292, Oprea1_790775, SCHEMBL21639, BSPBio_000203, BSPBio_001929, Carbamazepine (iv, epilepsy), KBioGR_000724, KBioSS_000516, MLS001055475, MLS001074172, MLS002548877, BIDD:GT0479, DivK1c_000388, DivK1c_003750, SPECTRUM1500159, SPBio_000170, SPBio_002124, CARBAMAZEPINE, U.S.P., BPBio1_000225, GTPL5339, ZINC4785, DTXSID4022731, SCHEMBL19838283, HMS501D10, HMS640O02, KBio1_000388, KBio2_000516, KBio2_003084, KBio2_005652, KBio3_001149, WLN: T C676 BNJ BVZ, AOB5783, Carbamazepine (JP17/USP/INN), SPD-417, Carbamazepine, analytical standard, MolPort-000-710-574, MolPort-023-220-275, NINDS_000388, HMS1568K05, HMS1920I17, HMS2090M07, HMS2091O19, HMS2095K05, HMS2233G16, HMS3039K09, HMS3259B21, HMS3260L06, HMS3372J13, HMS3657G03, HMS3712K05, Pharmakon1600-01500159, 85756-57-6 (di-hydrate), ACT02606, BCP21380, HY-B0246, KS-00000KI8, 5-Carbomoyl-5H-dibenzo(b,f)azepine, Tox21_110104, Tox21_202273, Tox21_300195, Tox21_500292, BBL005372, BDBM50003659, BG0497, CCG-38931, GP8250, MFCD00005073, NSC755920, s1693, STK177357, STL453548, 11-benzo[b][1]benzazepinecarboxamide, 5H-Dibenz[b,f]azepine-5-carboxamine, Carbamazepine 1.0 mg/ml in Methanol, AKOS003235644, AKOS025397243, IMED104589831, Tox21_110104_1, 5H-Dibenz[b,f]azepine-5- carboxamide, AC-9538, AN-6325, Carbamazepine (iv, epilepsy), Lundbeck, CS-2225, DB00564, KS-5146, LP00292, MCULE-9121567287, NC00679, NSC-169864, NSC-755920, 5H-Dibenz[ b, f]azepine-5-carboxamide, CDS1_002710, IDI1_000388, 5H-Dibenzo[b,f]azepine-5-carboxamide #, NCGC00015234-01, NCGC00015234-02, NCGC00015234-03, NCGC00015234-04, NCGC00015234-05, NCGC00015234-06, NCGC00015234-07, NCGC00015234-08, NCGC00015234-09, NCGC00015234-10, NCGC00015234-12, NCGC00015234-13, NCGC00015234-14, NCGC00015234-15, NCGC00015234-16, NCGC00015234-19, NCGC00023877-03, NCGC00023877-04, NCGC00023877-05, NCGC00023877-06, NCGC00023877-07, NCGC00023877-08, NCGC00253982-01, NCGC00259822-01, NCGC00260977-01, AJ-08227, AJ-08230, AK116064, BC200975, CC-25382, CC-25383, CPD001227191, H495, LS-60362, SAM002264603, SC-16243, ST075773, ZB000594, (z)-5h-dibenzo[b,f]azepine-5-carboxamide, SBI-0050280.P004, 5H-dibenzo[b,f]azepine-5-carboximidic acid, AB0070254, AB1009530, KB-246109, ST2418853, EU-0100292, FT-0602927, FT-0696814, H2605, EN300-21678, BIM-0050280.0001, C 4024, C06868, Carbamazepine, meets USP testing specifications, D00252, AB00051931-17, AB00051931-18, AB00051931_19, AB00051931_20, A820074, C-13993, I06-0863, SR-01000000229-2, SR-01000000229-4, SR-01000000229-7, BRD-K71799949-001-06-7, Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals, F0348-2551, Z2199879032, Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine), 5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A, Carbamazepine, British Pharmacopoeia (BP) Reference Standard, Carbamazepine, European Pharmacopoeia (EP) Reference Standard, Carbamazepine, United States Pharmacopeia (USP) Reference Standard, 2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide, Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material, Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt